-
Nanopore single-molecule sequencing to investigate mitochondrial DNA CpG methylation in Parkinson’s disease
-
Natural History of Probable MSA in India: A Prospective Cohort Study
-
Neural correlates of executed compared to imagined writing and drawing movements. An fMRI study
-
Neural oscillations modulation during working memory in premanifest and early Huntington’s disease
-
Neural Signals in the Cerebellar Nuclei Gate the Manifestation of Dystonia-Associated Symptoms in Mice
-
Neuro-Behavioral Therapy for Functional Movement Disorders: Conceptual Framework and Future Directions
-
Neuroanatomical signatures of genetic risk for Parkinson’s Disease in healthy adults
-
Neurofilament light chain serum levels in E46K-SNCA mutation carriers
-
Neurofilament light is related to fractional anisotropy in early Parkinson’s diesease
-
Neurogenetic Traits Outline Vulnerability to Cortical Disruption in Parkinson’s Disease
-
Neuroimaging associations to gait impairments in progressive supranuclear palsy
-
Neuroinflammation and Anti-Psychotic Drugs Induced Hyperkinesia or Dystonia in Treatment of Organic Brain Psychoses and Schizophrenia
-
Neuroleptic Malignant Syndrome: Case Series of Movement Disorders Emergency
-
Neuronal intranuclear inclusion disease tremor-dominant subtype: a mimicker of essential tremor
-
Neurophysiological features of the premotor cortex excitability parameters after a course of therapeutic transcranial magnetic stimulation in patients with Parkinson’s disease stage II living in the Zaporizhzhya region
-
Neuroprotective Epigenetic and DNA-Repair Molecular Mechanisms of Acetyl-L-Carnitine and Astaxanthin Against 6-OHDA Induced Parkinsonism in Aged Rats
-
Neuropsychiatric evaluation in patients with functionel movements disorders
-
Neuropsychiatric Issues in Parkinson’s Disease
-
Neutralizing Antibody Conversion With OnabotulinumtoxinA From Global Studies Across Multiple Indications With A Focus On Movement Disorders: A Meta-Analysis
-
New insight into REM-sleep atonia circuits underlying REM sleep behavior disorder in living humans
-
New presenilin-1 missense variant (p.Pro88Arg) characterized by initial progressive supranuclear palsy like phenotype.
-
New-onset movement disorders in patients with COVID-19 from two centers in Western India
-
Next-generation sequencing of plasma-associated extracellular vesicle miRNAs as potential biomarkers for Parkinson’s disease and its prodromal stage
-
Night Vision Blindness Should Be Discussed with our Parkinson’s Disease Patients – sooner rather than later.
-
NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson’s Disease
-
Non-invasive imaging markers of iron accumulation in Multiple System Atrophy
-
Non-Motor Symptoms in Cervical Dystonia Patients
-
Non-motor symptoms in Parkinson’s disease
-
Non-Motor Symptoms Progression After 2 years Follow-up in Parkinson´s Disease. Results from the COPPADIS Cohort and Comparison with a Control Group
-
NON-STRUCTURAL HEMICHOREA: REPORT OF NINE CASES
-
Non-Tremor Motor Dysfunction is Associated with AD Biomarkers in Lewy Body Dementias
-
Nonmotor effects of subthalamic stimulation in Parkinson’s disease motor subtypes
-
Nonmotor Symptoms in Huntington disease in relation to the Diagnostic Confidence Level
-
Normal chorein protein signal on Western blot despite VPS13A mutations in VPS13A disease
-
Normal-sized Perivascular Space in Basal Ganglia Related to Motor Phenotypes in Parkinson Freezers
-
Normative data for six standardized motor tasks in healthy adults
-
Novel approach to MDS-UPDRS monitoring in clinical trials: Longitudinal Item Response Theory Models
-
Novel Cognitive Markers for Early Diagnosis and Monitoring of Progressive Supranuclear Palsy
-
Novel PLA2G6 Mutation Presenting as Early-Onset Parkinson’s Disease
-
Novel quantitative measures with standardised graphical tasks to objectively assess subtle changes in fine motor skill in diagnosing and monitoring of Parkinson’s disease
-
Nurse-led rapid access mental health clinic: a new care pathway in Parkinson’s disease
MDS Virtual Congress 2021
September 17-22, 2021. Virtual Congress. www.mdscongress.org